(Q51820064)
Statements
A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients (English)
Djura Piersma
Els M J J Berns
Miriam Verhoef-Post
Andre G Uitterlinden
Huibert A P Pols
Axel P N Themmen